Direxion Shares ETF Trust (PILL)
Verwaltungsgesellschaft · ARCX · Serie S000050532 · Auf SEC EDGAR ansehen ↗
- Nettovermögen
- $12.9M
- Bestände
- 65
- Stand
- 30. April 2026 veraltet
- Gewichtung der Top-10-Positionen
- 40,83%
- Effektive Anzahl von Positionen
- 19,8
- Positionen über 1%
- 50
Auf dieser Seite
- Fondstransaktionen Geld, das jeden Monat in den Fonds fließt und aus ihm abfließt, aus N-PORT-Einreichungen.
- Bestände Jede Position, die der Fonds derzeit hält, mit Gewichtungen.
- Sektoraufschlüsselung Aufteilung der Fondsbestände nach Sektoren.
- Institutionelle Eigentümer 13F-Institutionen, die angeben, diesen ETF zu halten.
- Ähnliche Fonds Andere Fonds mit überlappenden Beständen oder vergleichbarer Größe.
Fondsflüsse (SEC-gemeldet)
- Letzter Monat (Apr 2026)
- -$557K
- Quartalsende Apr 2026
- -$5.8M
- Letzte 12 Monate
- -$9.4M
Mai 2025 – Apr 2026
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Vollständige Zusammensetzung 65 Beteiligungen
| Name | CUSIP | Wert | % | Bilanz | Kategorie | Land |
|---|---|---|---|---|---|---|
| GOLDMAN FINANCIAL | — | $2.4M | 18,99 | 2.448.306 | STIV | US |
| Unbekanntes Wertpapier | — | $660K | 5,12 | 1 | DE | US |
| DREYFUS GOVERNMENT CASH MANAGE | — | $483K | 3,75 | 483.278 | STIV | US |
| ORGANON & COMPANY | 68622V106 | $357K | 2,77 | 26.958 | EC | US |
| CORCEPT THERAPEUTICS INC | 218352102 | $238K | 1,85 | 5.114 | EC | US |
| ENLIVEN THERAPEUTICS INC | 29337E102 | $232K | 1,80 | 5.620 | EC | US |
| AXSOME THERAPEUTICS INC | 05464T104 | $225K | 1,74 | 1.081 | EC | US |
| OMEROS CORP | 682143102 | $211K | 1,64 | 14.463 | EC | US |
| PERRIGO COMPANY PLC | G97822103 | $208K | 1,62 | 17.588 | EC | IE |
| DEFINIUM THERAPEUTICS INC | 24477V105 | $203K | 1,57 | 9.260 | EC | CA |
| NEKTAR THERAPEUTICS | 640268306 | $200K | 1,55 | 2.353 | EC | US |
| TREVI THERAPEUTICS INC | 89532M101 | $199K | 1,54 | 14.451 | EC | US |
| TERNS PHARMACEUTICALS INC | 880881107 | $195K | 1,51 | 3.689 | EC | US |
| INDIVIOR PHARMACEUTICALS INC | 45579U109 | $193K | 1,50 | 5.257 | EC | US |
| PACIRA BIOSCIENCES INC | 695127100 | $193K | 1,49 | 7.557 | EC | US |
| HARROW INC | 415858109 | $189K | 1,47 | 4.670 | EC | US |
| JAZZ PHARMACEUTICALS PLC | G50871105 | $189K | 1,47 | 931 | EC | IE |
| HARMONY BIOSCIENCES HOLDINGS INC | 413197104 | $187K | 1,45 | 5.993 | EC | US |
| ROYALTY PHARMA PLC | G7709Q104 | $185K | 1,44 | 3.695 | EC | GB |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | $185K | 1,43 | 11.556 | EC | US |
| VIATRIS INC | 92556V106 | $185K | 1,43 | 12.352 | EC | US |
| CRINETICS PHARMACEUTICALS INC | 22663K107 | $181K | 1,40 | 4.666 | EC | US |
| ANI PHARMACEUTICALS INC | 00182C103 | $180K | 1,39 | 2.262 | EC | US |
| LIGAND PHARMACEUTICALS INC | 53220K504 | $179K | 1,39 | 780 | EC | US |
| MBX BIOSCIENCES INC | 55287L101 | $177K | 1,37 | 5.866 | EC | US |
| INNOVIVA INC | 45781M101 | $177K | 1,37 | 7.695 | EC | US |
| LIQUIDIA CORP | 53635D202 | $175K | 1,36 | 4.474 | EC | US |
| AMNEAL PHARMACEUTICALS INC | 03168L105 | $175K | 1,36 | 13.575 | EC | US |
| XERIS BIOPHARMA HOLDINGS INC | 98422E103 | $175K | 1,35 | 28.515 | EC | US |
| BRISTOL-MYERS SQUIBB COMPANY | 110122108 | $174K | 1,35 | 2.876 | EC | US |
| EDGEWISE THERAPEUTICS INC | 28036F105 | $172K | 1,34 | 5.567 | EC | US |
| OCULAR THERAPEUTIX INC | 67576A100 | $170K | 1,32 | 18.162 | EC | US |
| PFIZER INC | 717081103 | $169K | 1,31 | 6.321 | EC | US |
| NUVATION BIO INC | 67080N101 | $167K | 1,30 | 37.591 | EC | US |
| ZOETIS INC | 98978V103 | $166K | 1,28 | 1.441 | EC | US |
| ELANCO ANIMAL HEALTH INC | 28414H103 | $165K | 1,28 | 7.357 | EC | US |
| COLLEGIUM PHARMACEUTICAL INC | 19459J104 | $163K | 1,27 | 4.844 | EC | US |
| JOHNSON & JOHNSON | 478160104 | $163K | 1,27 | 710 | EC | US |
| MERCK & COMPANY INC | 58933Y105 | $162K | 1,26 | 1.485 | EC | US |
| ALUMIS INC | 022307102 | $162K | 1,25 | 6.551 | EC | US |
| ELI LILLY & COMPANY | 532457108 | $161K | 1,25 | 172 | EC | US |
| TARSUS PHARMACEUTICALS INC | 87650L103 | $157K | 1,22 | 2.469 | EC | US |
| SUPERNUS PHARMACEUTICALS INC | 868459108 | $156K | 1,21 | 3.242 | EC | US |
| PHIBRO ANIMAL HEALTH CORP | 71742Q106 | $155K | 1,20 | 2.911 | EC | US |
| EYEPOINT INC | 30233G209 | $153K | 1,18 | 11.564 | EC | US |
| PRESTIGE CONSUMER HEALTHCARE INC | 74112D101 | $150K | 1,16 | 2.662 | EC | US |
| AMPHASTAR PHARMACEUTICALS INC | 03209R103 | $146K | 1,13 | 6.654 | EC | US |
| THERAVANCE BIOPHARMA INC | G8807B106 | $132K | 1,02 | 7.856 | EC | KY |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | $131K | 1,01 | 11.659 | EC | US |
| RAPPORT THERAPEUTICS INC | 75383L102 | $130K | 1,01 | 3.931 | EC | US |
Seite 1
von 2
← Zurück
Weiter →
Sektoraufschlüsselung
Healthcare
70,5%
Sonstige/Nicht zugeordnet
29,5%
Institutionelle Eigentümer (13F) 8 Einreicher
Institutionen, die diese ETF in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann zweimal für separate Optionskontrakte erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
| Institution | Wert | % der verfolgten 13F | Aktien | Typ | Stand |
|---|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.348.938 | 69,77% | 74.692 | Aktien | 30. Juni 2026 |
| GTS SECURITIES LLC | $458.543 | 23,72% | 25.390 | Aktien | 30. Juni 2026 |
| Tower Research Capital LLC (TRC) | $105.163 | 5,44% | 5.823 | Aktien | 30. Juni 2026 |
| UBS Group AG | $18.385 | 0,95% | 1.018 | Aktien | 30. Juni 2026 |
| FINANCIAL CONSULATE, INC | $1.806 | 0,09% | 100 | Aktien | 30. Juni 2026 |
| SIMPLEX TRADING, LLC | $397 | 0,02% | 22 | Aktien | 30. Juni 2026 |
| MORGAN STANLEY | $38 | 0,00% | 2 | Aktien | 30. Juni 2026 |
| AlphaMark Advisors, LLC | $7 | 0,00% | 1.000 | Aktien | 31. Dezember 2024 |
Vergleichsfonds
Mehr von diesem Emittenten
| Fonds | AuM |
|---|---|
| SOXL Direxion Shares ETF Trust | $16.9B |
| SPXL Direxion Shares ETF Trust | $5.9B |
| TSLL Direxion Shares ETF Trust | $5.0B |
| TECL Direxion Shares ETF Trust | $4.7B |
| TMF Direxion Shares ETF Trust | $2.7B |
| FAS Direxion Shares ETF Trust | $2.0B |
| SOXS Direxion Shares ETF Trust | $1.9B |
| KORU Direxion Shares ETF Trust | $1.6B |
| TNA Direxion Shares ETF Trust | $1.5B |
| MUU Direxion Shares ETF Trust | $1.4B |
Ähnlich in der Größe
| Fonds | AuM |
|---|---|
| MPLY Strategy Shares | $13.2M |
| EEMO Invesco Exchange-Traded Fund Tr… | $13.2M |
| SZNE Pacer Funds Trust | $13.4M |
| SNPG DBX ETF Trust | $13.4M |
| UXJA First Trust Exchange-Traded Fun… | $13.5M |
| SDCP Virtus ETF Trust II | $12.8M |
| FARX Advisors' Inner Circle Fund II | $12.8M |
| EMIF iShares Trust | $12.7M |
| EQLT iShares Trust | $12.7M |
| TYLG Global X Funds | $12.7M |